We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » COMBINATION PRODUCTS ARE GROWTH OPPORTUNITY FOR DRUGMAKERS
COMBINATION PRODUCTS ARE GROWTH OPPORTUNITY FOR DRUGMAKERS
March 22, 2004
As medical researchers develop safer and more effective ways to deliver site-specific drug therapies, the FDA can expect to receive a significantly greater number of applications for combination products that blur the line between the agency’s medical product centers, say experts.